These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523 [TBL] [Abstract][Full Text] [Related]
12. Diet-induced obesity associated with steatosis, oxidative stress, and inflammation in liver. Peng Y; Rideout D; Rakita S; Lee J; Murr M Surg Obes Relat Dis; 2012; 8(1):73-81. PubMed ID: 21978752 [TBL] [Abstract][Full Text] [Related]
13. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice. Miller AM; Wang H; Bertola A; Park O; Horiguchi N; Ki SH; Yin S; Lafdil F; Gao B Hepatology; 2011 Sep; 54(3):846-56. PubMed ID: 21725996 [TBL] [Abstract][Full Text] [Related]
14. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531 [TBL] [Abstract][Full Text] [Related]
15. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis. Handa P; Maliken BD; Nelson JE; Morgan-Stevenson V; Messner DJ; Dhillon BK; Klintworth HM; Beauchamp M; Yeh MM; Elfers CT; Roth CL; Kowdley KV Hepatology; 2014 Jul; 60(1):133-45. PubMed ID: 24464605 [TBL] [Abstract][Full Text] [Related]
16. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis. Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806 [TBL] [Abstract][Full Text] [Related]
18. Fructose as a key player in the development of fatty liver disease. Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247 [TBL] [Abstract][Full Text] [Related]
19. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet. Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280 [TBL] [Abstract][Full Text] [Related]
20. Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease. Caputo M; Kurhe Y; Kumari S; Cansby E; Amrutkar M; Scandalis E; Booten SL; Ståhlman M; Borén J; Marschall HU; Aghajan M; Mahlapuu M FASEB J; 2021 May; 35(5):e21567. PubMed ID: 33891332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]